Deprince Race & Zollo Inc. Has $22.27 Million Position in Maximus, Inc. $MMS

Deprince Race & Zollo Inc. lifted its position in Maximus, Inc. (NYSE:MMS) by 147.1% during the third quarter, HoldingsChannel.com reports. The fund owned 243,695 shares of the health services provider’s stock after purchasing an additional 145,062 shares during the period. Deprince Race & Zollo Inc.’s holdings in Maximus were worth $22,266,000 at the end of the most recent quarter.

Other institutional investors have also recently bought and sold shares of the company. AQR Capital Management LLC increased its stake in Maximus by 177.2% in the first quarter. AQR Capital Management LLC now owns 1,173,329 shares of the health services provider’s stock valued at $79,341,000 after purchasing an additional 750,031 shares in the last quarter. Norges Bank acquired a new position in shares of Maximus in the 2nd quarter valued at $47,886,000. Boston Partners increased its position in shares of Maximus by 113.6% in the 2nd quarter. Boston Partners now owns 657,247 shares of the health services provider’s stock valued at $46,435,000 after buying an additional 349,529 shares in the last quarter. River Road Asset Management LLC acquired a new stake in Maximus during the 2nd quarter worth $18,073,000. Finally, Voya Investment Management LLC lifted its holdings in Maximus by 1,380.3% during the third quarter. Voya Investment Management LLC now owns 228,488 shares of the health services provider’s stock worth $20,877,000 after acquiring an additional 213,053 shares in the last quarter. Institutional investors and hedge funds own 97.21% of the company’s stock.

Maximus Stock Down 0.0%

MMS stock opened at $86.93 on Friday. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.64 and a quick ratio of 1.64. The stock has a market capitalization of $4.73 billion, a P/E ratio of 15.63 and a beta of 0.56. Maximus, Inc. has a fifty-two week low of $63.77 and a fifty-two week high of $92.50. The business has a 50-day moving average of $84.83 and a 200-day moving average of $81.84.

Maximus (NYSE:MMS) last released its earnings results on Thursday, November 20th. The health services provider reported $1.62 EPS for the quarter, missing the consensus estimate of $1.63 by ($0.01). The firm had revenue of $1.32 billion during the quarter, compared to the consensus estimate of $1.34 billion. Maximus had a net margin of 5.87% and a return on equity of 25.23%. The company’s revenue was up .2% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.46 EPS. Maximus has set its FY 2026 guidance at 7.950-8.250 EPS. On average, sell-side analysts anticipate that Maximus, Inc. will post 6.15 earnings per share for the current fiscal year.

Maximus Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Monday, December 1st. Investors of record on Friday, November 14th were given a $0.30 dividend. The ex-dividend date of this dividend was Friday, November 14th. This represents a $1.20 dividend on an annualized basis and a yield of 1.4%. Maximus’s dividend payout ratio (DPR) is 21.58%.

Wall Street Analysts Forecast Growth

MMS has been the subject of several recent analyst reports. Zacks Research downgraded Maximus from a “strong-buy” rating to a “hold” rating in a report on Monday, October 27th. Weiss Ratings reissued a “buy (b-)” rating on shares of Maximus in a research note on Monday, December 22nd. Two analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat, Maximus has an average rating of “Moderate Buy” and an average target price of $90.00.

Insider Transactions at Maximus

In other Maximus news, insider Michelle F. Link sold 4,039 shares of Maximus stock in a transaction on Wednesday, December 3rd. The shares were sold at an average price of $86.84, for a total value of $350,746.76. Following the sale, the insider directly owned 19,542 shares in the company, valued at approximately $1,697,027.28. The trade was a 17.13% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Insiders own 1.60% of the company’s stock.

About Maximus

Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.